Women and children have unique health needs that are too often neglected. Whether it’s maternal and child health, menstrual health or infectious disease, these challenges drive some of the biggest global inequities in health today. Uplifting the wellbeing of women and children can help us build resilient networks of care and healthier communities. At Burnet, we're working to improve women's and children's health in Australia and around the world.
Women’s and children's needs have been historically neglected in research. This has led to incomplete knowledge, gender bias and unequal health outcomes. Many of these disparities can be reduced through more inclusive research and equitable healthcare access.
Our work aims to address challenges such as:
postpartum complications
under-nutrition for mothers and babies
lack of access to lifesaving childhood vaccines
midwife and health worker shortages
parent-to-child transmission of HIV, syphilis and hepatitis B
lack of investment in menstrual health
mental illness and challenges to mental health
discrimination and social and structural violence.
A new Burnet study examined how probiotics could potentially treat gut-related conditions in pregnant women.
Burnet has helped lead major progress on women’s and children’s health.
We helped launch the Global Maternal and Newborn Health Platform. As part of this, we're gathering data from more than 90,000 women and their newborns in 74 hospitals. We're building a knowledge base of women's experiences to improve childbirth and newborn care across the globe.
For more than 10 years, we’ve help lead the Healthy Mothers, Healthy Babies program. The program is a wide-ranging set of studies in East New Britain, Papua New Guinea, that explores common issues with maternal and child health as well as strategies to respond. The program addresses health risks like childhood stunting and nutrition, as well as sexually transmitted infections and newborn sepsis.
Using biostatistics models, we developed the Optima Nutrition tool. This tool is used by the World Bank, governments and other organisations to analyse how they can efficiently improve childhood nutrition. Our research also informed the United Nations Pacific Regional Roadmap for Triple Elimination.
We've contributed to influential reports around the world, including reports published by the World Health Organization. These include:
We’ve helped develop international clinical guidelines. This includes research that helped inform the World Health Organization’s guidelines on postpartum haemorrhage.
With commercial and government support, our lab researchers developed a groundbreaking rapid test for syphilis infections. This is the first test on the global market that identifies active syphilis infections compared to past, treated infections.
We’ve made menstrual health a priority in our public health work. Menstrual health, or health and wellness related to periods and the menstrual cycle, has been neglected for years. It’s not a hygiene issue—menstrual health is a health and human rights priority. We’ve developed and validated new tools to measure menstrual health experiences. We’re also launched landmark studies on adolescent menstrual health.
We work directly with women, children and health workers to better understand their needs, and we develop evidence-based interventions to improve maternal and child health. These include education programs, tools, diagnostics and policy guidance. We test these interventions with clinical trials and world-leading studies.
People with direct experience often know what they need in order to thrive. We use a ‘co-design’ approach by partnering with local women, health workers and community members. We work with those most affected to ensure that research and interventions are effective.
We support midwifery education and training across the Pacific, including in Solomon Islands and Vanuatu. We also develop workshops and campaigns to increase awareness and delivery of important childhood vaccines. We run leadership training for women, supporting them with skills to advocate for better health in their communities.
There are 3 major infections that can pass from parent to infant during pregnancy, childbirth and breastfeeding. These are HIV, syphilis and hepatitis B virus. Efforts to prevent 'mother-to-child transmission' of these infections are called 'triple elimination'. We work with partners to develop toolkits, guidelines and systems that help countries reach their triple elimination goals.
Our lab researchers are working on new ways to detect or diagnose disease. We're also looking for indicators (biomarkers) that could be linked to vaginal inflammation, HIV, preterm birth and other health risks.
Through global collaboration, we lead studies that advance our knowledge of women’s and children’s health. This includes world-first studies on:
adolescent menstrual health
pre-eclampsia risk-screening and prevention
new medicines for pregnancy-related conditions
hepatitis B treatment.
Hundreds of women continue to die each day from pregnancy or childbirth complications. Many of these deaths are easily preventable. There’s still work to do to scale up our interventions and address barriers to women’s health, maternal health and child health. At Burnet, we’re continuing to explore how aspects of sex and gender impact health and social outcomes among people who face marginalisation and discrimination.
American Journal of Obstetrics & Gynecology MFM
Annie Tan, Kate Mills, Annie R.A. McDougall, Maureen Makama, Phi‐Yen Nguyen, Elizabeth Armari, Joshua P. Vogel, Kate Mills, Annie R.A. McDougall, Annie Tan
Research Square (Research Square)
Joshua P. Vogel, Elizabeth Armari, Caroline Homer
The Lancet Global Health
Grace Simpson, Joshua P. Vogel, Jenny Jung, Dvora Kluwgant, Caroline Homer, Joshua P. Vogel, Jenny Jung, Grace Simpson, Dvora Kluwgant, Caroline Homer
The Pediatric Infectious Disease Journal
Naomi Spotswood, James G. Beeson
BMC Health Services Research
Alyce N. Wilson, Pele Melepia, Rose Suruka, Priscah Hezeri, Dukduk Kabiu, Joshua P. Vogel, James G. Beeson, Michelle J. L. Scoullar, Elissa Kennedy, Caroline Homer
BMC Pregnancy and Childbirth
Donya Eghrari, Michelle J. L. Scoullar, Alyce N. Wilson, Elizabeth Peach, Elissa Kennedy, Leanne J. Robinson, Freya J. I. Fowkes
An investigation of the effects of long-acting contraceptives on the female genital tract.
We’re developing a diagnostic test for genital inflammation to identify women with asymptomatic sexually transmitted infections and bacterial vaginosis.
A multi-country trial of antenatal corticosteroid medication for pregnant people with a high probability of preterm birth.